Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Jan:22 Suppl 1:26-45.
doi: 10.1111/jvh.12351.

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

A Hatzakis  1 , V Chulanov, A C Gadano, C Bergin, Z Ben-Ari, J Mossong, I Schréter, O Baatarkhuu, S Acharya, I Aho, A C Anand, M I Andersson, V Arendt, P Arkkila, K Barclay, F Bessone, S Blach, N Blokhina, C R Brunton, G Choudhuri, L Cisneros, E A Croes, Y A Dahgwahdorj, O Dalgard, J R Daruich, N R Dashdorj, D Davaadorj, R J de Knegt, M de Vree, C Estes, R Flisiak, E Gane, E Gower, W Halota, C Henderson, P Hoffmann, J Hornell, D Houlihan, S Hrusovsky, P Jarčuška, D Kershenobich, K Kostrzewska, P Kristian, M Leshno, Y Lurie, A Mahomed, N Mamonova, N Mendez-Sanchez, S Norris, E Nurmukhametova, P Nymadawa, M Oltman, J Oyunbileg, Ts Oyunsuren, G Papatheodoridis, N Pimenov, N Prabdial-Sing, M Prins, S Radke, A Rakhmanova, K Razavi-Shearer, H W Reesink, E Ridruejo, R Safadi, O Sagalova, J F Sanchez Avila, R Sanduijav, V Saraswat, C Seguin-Devaux, S R Shah, I Shestakova, A Shevaldin, O Shibolet, M O Silva, S Sokolov, M Sonderup, K Souliotis, C W Spearman, T Staub, C Stedman, E A Strebkova, D Struck, V Sypsa, K Tomasiewicz, L Undram, A J van der Meer, D van Santen, I Veldhuijzen, F G Villamil, S Willemse, E Zuckerman, F R Zuure, P Puri, H Razavi
Affiliations
Comparative Study

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2

A Hatzakis et al. J Viral Hepat. 2015 Jan.

Abstract

Morbidity and mortality attributable to chronic hepatitis C virus (HCV) infection are increasing in many countries as the infected population ages. Models were developed for 15 countries to quantify and characterize the viremic population, as well as estimate the number of new infections and HCV related deaths from 2013 to 2030. Expert consensus was used to determine current treatment levels and outcomes in each country. In most countries, viremic prevalence has already peaked. In every country studied, prevalence begins to decline before 2030, when current treatment levels were held constant. In contrast, cases of advanced liver disease and liver related deaths will continue to increase through 2030 in most countries. The current treatment paradigm is inadequate if large reductions in HCV related morbidity and mortality are to be achieved.

Keywords: HCV; diagnosis; disease burden; epidemiology; hepatitis C; incidence; mortality; prevalence; treatment.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources